4-French–Compatible Endovascular Material Is Safe and Effective in the Treatment of Femoropopliteal Occlusive Disease: Results of the 4-EVER Trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

4-French–Compatible Endovascular Material Is Safe and Effective in the Treatment of Femoropopliteal Occlusive Disease: Results of the 4-EVER Trial

Published:2013-12 Issue:6 Volume:20 Page:746-756
ISSN:1526-6028
Container-title:Journal of Endovascular Therapy
language:en
Short-container-title:Journal of Endovascular Therapy

Author:

Bosiers Marc,Deloose Koen,Callaert Joren,Keirse Koen,Verbist Jürgen,Hendriks Jeroen,Lauwers Patrick,D'Archambeau Olivier,Scheinert Dierk,Torsello Giovanni,Peeters Patrick

Publisher

International Society of Endovascular Specialists

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,Surgery

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Peripheral Vascular Interventions in an Ambulatory Setting: A Single-Center Retrospective Analysis;Annals of Vascular Surgery;2022-09

2. Comparative Analysis of Endovascular Intervention and Endarterectomy in Patients with Femoral Artery Disease: A Systematic Review and Meta-Analysis;Hematology Reports;2022-06-01

3. Stents With Torsional Strength for Superficial Femoral Artery Disease: The Prospective Q3-Registry;Journal of Endovascular Therapy;2022-01-07

4. The consequences of angiography and angioplasty of the lower limb in one stage by simultaneous ipsilateral double puncture technique and in two-stage delayed technique: a comparative study;Chirurgia;2021-02

5. An Update on Drug-eluting Technology in Peripheral Arteries to Treat Peripheral Arterial Disease;Heart International;2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP